Antimicrobial and Diagnostic Stewardship Program
Northwestern Medicine is committed to improving antibiotic use to ensure that antibiotics remain effective treatment options.
Our mission is to advocate for optimal antimicrobial use and diagnostic testing for every patient to improve clinical outcomes, prevent drug resistance, enhance quality and safety, and advance research. Our vision is to protect antimicrobials and promote a culture of stewardship across our health system and communities. Our goals for 2024 are to advance stewardship efforts to optimize outcomes and antibiotic use to provide a consistent level of care across all of Northwestern Medicine. |
News and Events
|
This website is primarily intended to be used as a resource for NM clinicians. Guidance is designed to improve and standardize the quality of patient care, but it should not be used without clinical judgement.
Recent Updates
Skin and Soft Tissue Infection (SSTI) Clinical Pathway & Treatment Guidance
May 2024 | System-wide Restricted Antimicrobial Use Criteria Mar 2024 | System-wide |
Biofire® FilmArray® Blood Culture Identification Panel Clinician Guidance
Mar 2024 | System-wide Renal Dosing Guidance Jun 2024 | System-wide |
Beta-Lactam Allergy Risk Assessment and Cross-Reactivity Chart
Jan 2024 | System-wide Urinary Infection Treatment Guidance Apr 2023 | System-wide |
rESOURCES
Why Our Work Matters
The Northwestern Medicine Antimicrobial Stewardship Team works continuously to support our clinicians in their decision to prescribe antibiotic orders. Please reach out to your hospital's antibiotic stewardship team for resources and clinical decision support.
|